3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-09-18 10:37 UTC
EQS-News: mAbxience / Key word(s): Agreement/Miscellaneous mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide 18.09.2026 / 12:35 CET/CEST The issuer is solely responsible for the content of this announcement. ═══════════════════════════════════════════════════════════════════════
News 2026-09-18 10:17 UTC
mAbxience and Sandoz announced a licensing, development, and manufacturing collaboration agreement to advance biosimilar access worldwide.
News 2026-09-18 05:17 UTC
Sandoz Group AG / Key word(s): Agreement Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines 18.09.2026 / 07:15 CET/CEST ══════════════════════════════════════════════════════════════════════════════════════════════════════ Media Release • Agreement for emicizum